Skip to main content

Table 4 Risk of T2DM by statin use, stratified by age groups, BMI categories, hypertension, CVD and follow-up time

From: Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink

PS [5-95%] Incident T2DM per 1000 person-years (95% CI) Hazard ratio (95% CI) adjusted for age and propensity score
(N = 1,448,993) Exposed Unexposed
Age    
30-39 23.16 (21.70-24.72) 3.89 (3.59-4.21) 4.68 (4.12-5.31)
40-49 25.13 (24.43-25.84) 6.70 (6.80-7.20) 2.84 (2.70-2.99)
50-59 25.22 (24.79-25.65) 10.83 (10.65-11.00) 1.87 (1.82-1.93)
60-69 23.88 (23.52-24.23) 14.53 (14.31-14.75) 1.34 (1.30-1.37)
70-79 22.94 (22.52-23.36) 17.81 (17.49-18.14) 1.15 (1.11-1.19)
80-85 20.30 (19.48-21.15) 13.83 (13.32-14.36) 1.25 (1.17-1.34)
BMI, kg/m 2    
<20 11.71 (10.79-12.70) 6.76 (6.38-7.15) 1.20 (1.06-1.36)
20-25 13.22 (12.92-13.53) 6.54 (6.41-6.67) 1.51 (1.45-1.57)
>25 28.99 (28.72-29.75) 17.18 (17.01-17.35) 1.40 (1.38-1.43)
Hypertension 26.41 (26.06-26.77) 21.80 (21.49-22.12) 1.04 (1.01-1.07)
No hypertension 22.32 (22.06-22.57) 9.69 (9.58-9.80) 1.92 (1.88-1.95)
CVD 23.42 (23.00-23.85) 21.91 (21.32-22.53) 0.86 (0.82-0.89)
No CVD 24.04 (23.80-24.28) 11.63 (11.53-11.74) 1.70 (1.67-1.72)
Follow up time (years)    
0-1 yr 19.97 (19.52-20.42) 11.53 (11.33-11.74) 1.52 (1.47-1.57)
1-3 yr 20.11 (19.77-20.44) 13.55 (13.37-13.74) 1.22 (1.19-1.25)
3-5 yr 24.56 (24.12-25.00) 11.61 (11.38-11.84) 1.73 (1.68-1.80)
5-10 yr 30.04 (29.55-30.53) 10.85 (10.59-11.12) 2.25 (2.17-2.34)
10-15 yr 34.93 (33.52-36.39) 10.20 (9.38-11.10) 3.05 (2.71-3.43)
15-20 yr 42.24 (36.90-48.36) 12.24 (9.08-16.51) 3.63 (2.44-5.38)
20-25 yr 13.10 (1.84-93.00) n.e. n.e.
  1. n.e - no estimation.